FDA Approves Unknown Drug — LUPIN
LUPIN has received FDA approval for ANDA 207694, a move that is likely to strengthen the company’s competitive positioning and broaden its market share in the relevant therapeutic …
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
LUPIN has received FDA approval for ANDA 207694, a move that is likely to strengthen the company’s competitive positioning and broaden its market share in the relevant therapeutic …
The Federal Reserve's Federal Open Market Committee issued a statement regarding monetary policy decisions. The statement addresses current economic conditions and the Fed's policy…
The FDA released results from its largest and most rigorous examination of chemical contaminants in infant formula available in the U.S. market. The comprehensive testing represent…
# FDA Approves Sunshine Lake Pharma Biologic Application The U.S. Food and Drug Administration has approved Biologics License Application (BLA) 761412 for Sunshine Lake Pharma Co …
# FDA Approves HUMANWELL's Generic Drug Application HUMANWELL has received FDA approval for its abbreviated new drug application (ANDA 218740), potentially expanding its portfolio…
The FDA announced two major steps to advance real-time clinical trials (RTCT) implementation. The initiative aims to modernize clinical trial processes.
# FDA Approves Sun Pharma Canada Generic Drug Sun Pharma Canada has received FDA approval for a generic drug application (ANDA213919), expanding the company's portfolio in the com…
Biocon Pharma’s acquisition of an FDA approval for a generic drug substance on April 28, 2026, is anticipated to expand its United States market footprint and drive future top-line…
Micro Labs is poised to capitalize on the upcoming approval, with the generic launch expected to introduce competitive pricing pressures and capture market share from established b…
The Federal Reserve Board has approved an application submitted by OceanFirst Financial Corp. The approval permits the company to proceed with its requested regulatory action.
The Federal Reserve Board has approved an application submitted by Banco de Credito del Peru. The approval allows the Peruvian financial institution to proceed with its requested r…
President Trump issued an Executive Order on April 18 directing HHS to accelerate access to treatments for serious mental illness, including treatment-resistant conditions. The FDA…
# FDA Approves Generic Fingolimod; Alembic Pharmaceuticals Enters Multiple Sclerosis Market The FDA has approved Alembic Pharmaceuticals Inc.'s generic fingolimod hydrochloride or…
The Federal Reserve and banking agencies have finalized modifications to the community bank leverage ratio framework. The changes are designed to enhance regulatory flexibility for…
The FDA approved Otarmeni (lunsotogene parvec-cwha), marking the first dual AAV vector-based gene therapy for genetic hearing loss treatment. The approval was granted under the Nat…
CMS and FDA announced the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway to accelerate Medicare patient access to FDA-designated Class II and Cl…
# FDA Approves Generic Glycerol Phenylbutyrate; Zydus Pharmaceuticals Entry Expected to Intensify Competition The FDA has granted approval to Zydus Pharmaceuticals USA Inc. for a …
SciGen Pharmaceuticals is positioned for potential revenue growth and market entry following the FDA approval of its ANDA, a regulatory clearance expected to drive investor optimis…
The Federal Reserve Board has taken an enforcement action against a former employee of First Financial Bank. Details of the specific violations or sanctions were not provided in th…
# FDA Approves Anthea Pharma's Generic Bupivacaine Hydrochloride for Epidural Use Anthea Pharma Private Limited received FDA approval for its generic bupivacaine hydrochloride epi…